Citizens JMP analyst Silvan Tuerkcan reiterated a Market Perform rating price target on Intellia Therapeutics (NASDAQ: NTLA).The analyst commented, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE